Next 2 years profit

**Biosynex's expected profit over the next 2 years is uncertain**. Here's why: 1. **Recent Growth**: Biosynex has reported a 26% increase in sales for the first half of 2024, which is a positive sign. This growth could continue if the company successfully executes its strategic plans. 2. **Strategic Acquisitions**: The company's growth is attributed to the contribution of its latest strategic acquisitions and good sales trends for its organic products. If Biosynex continues to make strategic acquisitions and innovate, it could drive future growth. 3. **Debt Restructuring**: Biosynex is continuing discussions with its banking pool to restructure its debt. This process could improve the company's financial health and potentially lead to higher profits. 4. **Market Performance**: The company's stock price has risen by more than 22% following the half-yearly publication, indicating investor confidence. This confidence could translate into higher profits if the company delivers on its growth promises. 5. **Challenges**: However, Biosynex has faced challenges, including a significant drop in stock price and a decline in revenue. These issues could impact the company's profitability in the short term. 6. **Industry Trends**: The Medical Equipment industry is competitive, and companies face challenges in maintaining growth and profitability. Biosynex will need to navigate these industry trends to achieve its profit goals. 7. **Financial Health**: Biosynex's net loss for the full year 2023 was substantial, which is a concern for profitability. The company will need to address this issue to improve its financial health. In conclusion, while Biosynex has shown some positive signs of growth, there are also significant challenges and uncertainties that could impact its profitability over the next 2 years. Investors should closely monitor the company's progress on strategic initiatives, debt restructuring, and overall financial performance to make informed decisions.